Table 3.
Assessment of the degree of therapeutic appropriateness of the total study population and classified by severity classes in relation to the GOLD 2015 guidelines (Figure 2A–D)
| ALL | Group A* | Group B* | Group C* | Group D* | |
|---|---|---|---|---|---|
| In line with GL, n (%) | 419 (60.46) | 57 (40.14) | 110 (46.22) | 18 (43.9) | 234 (86.03) |
| Not in line with GL, n (%) | 205 (29.58) | 70 (49.30) | 109 (45.80) | 18 (43.9) | 8 (2.94) |
| No therapy, n (%) | 69 (9.96) | 15 (10.56) | 19 (7.98) | 5 (12.20) | 30 (11.03) |
| Total, n (%) | 693 (100) | 142 (100) | 238 (100) | 41 (100) | 272 (100) |
Notes:
*
GOLD classification.
Abbreviations: GL, guideline; GOLD, Global initiative for chronic Obstructive Lung Disease.